NeoGenomics Launches $275M Convertible Notes Offering, Plans Debt Refinancing and Share Repurchases
NEO has more than doubled off its 52-week low of $4.72.
Summary
NeoGenomics has launched a private offering of $275 million in convertible senior notes due 2032, with an option for an additional $41.25 million. This follows an 8-K filing earlier today announcing the proposed offering. The proceeds will be used to partially repay existing 2028 convertible notes, fund up to $25 million in share repurchases from certain note purchasers, and for general corporate purposes. The company also expects to enter into capped call transactions to reduce potential dilution.
At the time of this announcement, NEO was trading at $10.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $4.72 to $13.74. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.